| 2025 | 2024 | 2023 | 2022 | 2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -1,7 M € | +5.0% | -1,7 M € | -238.2% | -515,8 k € | +74.0% | -2,0 M € | -35.4% | -1,5 M € | |
| EBITDA | -3,2 M € | -25.8% | -2,6 M € | -174.7% | -930,1 k € | +58.3% | -2,2 M € | -48.8% | -1,5 M € | |
| Operating profit | -15,7 M € | -82.2% | -8,6 M € | -112.4% | -4,1 M € | -35.2% | -3,0 M € | -72.6% | -1,7 M € | |
| Profit/loss | -14,8 M € | -72.7% | -8,6 M € | -105.8% | -4,2 M € | -33.0% | -3,1 M € | -75.8% | -1,8 M € | |
| Equity | 29,0 M € | +328.2% | 6,8 M € | +409.4% | -2,2 M € | -210.9% | 2,0 M € | +264.7% | 541,0 k € | |
| Total assets | 30,9 M € | +250.5% | 8,8 M € | +66.2% | 5,3 M € | +96.1% | 2,7 M € | -39.4% | 4,5 M € | |
| Cash | 656,4 k € | -91.5% | 7,8 M € | +103.6% | 3,8 M € | +140.8% | 1,6 M € | -39.4% | 2,6 M € | |
| Debts | 1,9 M € | -3.8% | 2,0 M € | -72.0% | 7,2 M € | +1044.3% | 625,9 k € | -81.6% | 3,4 M € | |
| Staff | 11 | 5,4 | — | — | 0,7 | |||||
Public limited company · Leuven · incorporated on 13/03/2019 · 11,0 ETP
Public limited company loss-making in the latest fiscal year. Cash position declining (-91.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
AUGUSTINE THERAPEUTICS is a Public limited company incorporated in 2019. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Leuven. It employs on average 11,0 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette